Annals of Surgical Oncology

, 18:3079 | Cite as

Feasibility of Percutaneous Excision Followed by Ablation for Local Control in Breast Cancer

  • V. Suzanne Klimberg
  • Cristiano Boneti
  • Laura L. Adkins
  • Maureen Smith
  • Eric Siegel
  • Vladimir Zharov
  • Scott Ferguson
  • Ronda Henry-Tillman
  • Brian Badgwell
  • Soheila Korourian
American Society of Breast Surgeons



Percutaneous ablation of breast cancer has shown promise as a treatment alternative to open lumpectomy. We hypothesized that percutaneous removal of breast cancer followed by percutaneous ablation to sterilize and widen the margins would not only provide fresh naive tissue for tumor marker and research investigation, but also better achieve negative margins after ablation.


Patients diagnosed by percutaneous biopsy (ultrasound or stereotactic-guided) with breast cancer ≤1.5 cm, >1 cm from the skin, and ≤1 cm residual disease and no multicentric disease by magnetic resonance imaging were accrued to this institutional review board–approved study. Patients were randomized to laser versus radiofrequency ablation. The ultrasound-guided ablation was performed in the operating room and followed by immediate excision, whole-mount pathology with proliferating cell nuclear antigen staining, and reconstruction.


Twenty-one patients were enrolled onto the study. Fifteen patients received radiofrequency ablation, and all showed 100% ablation and negative margins. Magnetic resonance imaging was helpful in excluding multicentric disease but less so in predicting presence or absence of residual disease. Seven of these patients showed no residual tumor and eight showed residual dead tumor (0.5 ± 0.7 cm, range 0.1–2.5 cm) at the biopsy site with clear margins. The laser arm (3 patients) pathology demonstrated unpredictability of the ablation zone and residual live tumor.


This pilot study demonstrates the feasibility of a novel approach to minimally invasive therapy: percutaneous excision and effective cytoreduction, followed by radiofrequency ablation of margins for the treatment of breast cancer. Laser treatment requires further improvement.


Proliferate Cell Nuclear Antigen Radiofrequency Ablation Doppler Imaging Ablation Zone Percutaneous Biopsy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



Supported by the Tenenbaum Breast Cancer Research Fund, Little Rock, Arkansas Supported by the Fashion Footwear Association of New York (FFANY/QVC) Supported by the National Institute of Health (NIH) Grant #5 R21-CA097715 in collaboration with Ethicon Endo-surgical, Inc and RITA/AngioDynamics.


V.S. Klimberg, MD has a grant with Angiodynamics for another project, “Multicenter Registry for eRFA.” Angiodynamics bought the RITA company that supplied the probes for this study through an NIH grant.


  1. 1.
    Toi M, Winer EP, Inamoto T, et al. Identifying gaps in the locoregional management of early breast cancer: highlights from the Kyoto Consensus Conference. Ann Surg Oncol. In press.Google Scholar
  2. 2.
    Schnitt SJ, Abner A, Gelman R, et al. The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast-conserving surgery and radiation therapy. Cancer. 1994;74:1746–51.PubMedCrossRefGoogle Scholar
  3. 3.
    Spivak B, Khanna MM, Tafra L, Juillard G, Giulano AB. Margin status and local recurrence after breast-conserving surgery. Arch Surg. 1994;129:952–7.Google Scholar
  4. 4.
    Pezner RD, Lipsett JA, Desai K, et al. To boost or not to boost: decreasing radiation therapy in conservative breast cancer treatment when “inked” tumor resection margins are pathologically free of cancer. Int J Radiat Oncol Biol Phys. 1988;14:873–7.PubMedCrossRefGoogle Scholar
  5. 5.
    Fourquet A, Campana F, Zafrani B, et al. Prognostic factors of breast recurrence in the conservative management of early breast cancer: a 25 year follow-up. Int J Radiat Oncol Biol Phys. 1989;17:719–25.PubMedCrossRefGoogle Scholar
  6. 6.
    Wood BJ, Ramkaransingh JR, Fojo T, Walther MM, Libutti SK. Percutaneous tumor ablation with radiofrequency. Cancer. 2002;94:443–51.PubMedCrossRefGoogle Scholar
  7. 7.
    Jeffrey SS, Birdwell RL, Ikeda DM, et al. Radiofrequency ablation of breast cancer: first report of an emerging technology. Arch Surg. 1999;134:1064–8.PubMedCrossRefGoogle Scholar
  8. 8.
    Izzo F, Thomas R, Delrio P, et al. Radiofrequency ablation in patients with primary breast carcinoma: a pilot study in 26 patients. Cancer. 2001;92:2036–44.PubMedCrossRefGoogle Scholar
  9. 9.
    Fornage BD, Sneige N, Ross MI, et al. Small (2-cm) breast cancer treated with US-guided radiofrequency ablation: feasibility study. Radiology. 2004;231:215–24.PubMedCrossRefGoogle Scholar
  10. 10.
    Burack WE Jr, Agnese DM, Povoski SP, et al. Radiofrequency ablation of invasive breast carcinoma followed by delayed surgical excision. Cancer. 2003;98:1369–76.CrossRefGoogle Scholar
  11. 11.
    Hayashi AH, Silver SF, van der Westhuizen NG, et al. Treatment of invasive breast carcinoma with ultrasound-guided radiofrequency ablation. Am J Surg. 2003;185:429–35.PubMedCrossRefGoogle Scholar
  12. 12.
    Singletary SE, Fornage BD, Sneige N, et al. Radiofrequency ablation of early-stage invasive breast tumors: an overview. Cancer. 2002;8:177–80.CrossRefGoogle Scholar
  13. 13.
    Bown SG. Phototherapy of tumours. World J Surg. 1983;7:700–9.PubMedCrossRefGoogle Scholar
  14. 14.
    Steger AC, Lees WR, Walmsley K, Bown SG. Interstitial laser hyperthermia: a new approach to local destruction of tumors. BMJ. 1989;299:362–5.PubMedCrossRefGoogle Scholar
  15. 15.
    Masters A, Bown SG. Interstitial laser hyperthermia in tumour therapy. Ann Chir Gynaecol. 1990;79:244–51.PubMedGoogle Scholar
  16. 16.
    Stonn FK, Silbennan AW, Ramming KR, et al. Clinical then no chemotherapy: a controlled trial in advanced cancer patients. Cancer. 1984;53:863–8.CrossRefGoogle Scholar
  17. 17.
    Matthewson D, Coleridge-Smith P, O’Sullivan IP, Northfield TC, Bown SG. Biological effects of intrahepatic neodymium:yttrium–aluminum–garnet laser photocoagulation in rats. Gastroenterology. 1987;93:550–7.PubMedGoogle Scholar
  18. 18.
    Nolsoe CP, Torp-Pedersen S, Burcharth F, et al. Interstitial hyperthermia of colorectal liver metastases with a US-guided Nd-YAG laser with a diffuser tip: a pilot clinical study. Radiology. 1993;187:333–7.PubMedGoogle Scholar
  19. 19.
    Amin Z, Donald JJ, Masters A, et al. Hepatic metastases: interstitial laser photocoagulation with real-time US monitoring and dynamic CT evaluation of treatment. Radiology. 1993;187:339–47.PubMedGoogle Scholar
  20. 20.
    Jacques SL, Rastegar S, Motamedi M, et al. Liver photocoagulation with diode laser (805 nm) vs. Nd:YAG laser (1064 nm). Proc SPIE. 1992;1646:107–17.CrossRefGoogle Scholar
  21. 21.
    Schatz SW, Bown SG, Wyman DR, Groves IT, Wilson BC. Low-power interstitial Nd- YAG laser photocoagulation in normal rabbit brain. Lasers Med Sci. 1992;7:433–9.CrossRefGoogle Scholar
  22. 22.
    Hung WK, Ying M, Chan CM, Lam HS, Mak L. Minimally invasive technology in the management of breast disease. Breast Cancer. 2009;16:23–9.PubMedCrossRefGoogle Scholar
  23. 23.
    Arentz C, Baxter K, Boneti C, et al. Ten-year experience with hematoma-directed ultrasound-guided (HUG) breast lumpectomy. Ann Surg Oncol. 2010;17(Suppl 3):378–83.PubMedCrossRefGoogle Scholar
  24. 24.
    Bland KL, Gass J, Klimberg VS. Radiofrequency, cryoablation, and other modalities for breast cancer ablation. Surg Clin North Am. 2007;87:539–50, xii.Google Scholar
  25. 25.
    Nahirnyak VM, Moros EG, Novák P, Suzanne Klimberg V, Shafirstein G. Doppler signals observed during high temperature thermal ablation are the result of boiling. Int J Hyperthermia. 2010;26:586–93.PubMedCrossRefGoogle Scholar
  26. 26.
    Korourian S, Klimberg S, Henry-Tillman R, et al. Assessment of proliferating cell nuclear antigen activity using digital image analysis in breast carcinoma following magnetic resonance–guided interstitial laser photocoagulation. Breast J. 2003;9:409–13.PubMedCrossRefGoogle Scholar
  27. 27.
    Dowlatshahi K, Dieschbourg JJ, Bloom KJ. Laser therapy of breast cancer with 3-year follow-up. Breast J. 2004;10:240–3.PubMedCrossRefGoogle Scholar
  28. 28.
    Klimberg VS, Kepple J, Shafirstein G, et al. eRFA: excision followed by RFA—a new technique to improve local control in breast cancer. Ann Surg Oncol. 2006;13:1422–33.PubMedCrossRefGoogle Scholar
  29. 29.
    Fishbein MC, Meerbaum S, Rit J, et al. Early phase acute myocardial infarct size quantification: validation of the triphenyl tetrazolium chloride tissue enzyme staining technique. Am Heart J. 1981;101:593.Google Scholar
  30. 30.
    Bloom KJ, Dowlat K, Assad L. Pathologic changes after interstitial laser therapy of infiltrating breast carcinoma. Am J Surg. 2001;182:384–8.PubMedCrossRefGoogle Scholar
  31. 31.
    Johnson AT, Henry-Tillman RS, Smith LF, et al. Percutaneous excisional breast biopsy. Am J Surg. 2002;184:550–4.PubMedCrossRefGoogle Scholar
  32. 32.
    Noguchi M, Earashi M, Fujii H, Yokoyama K, Harada K, Tsuneyama K. Radiofrequency ablation of small breast cancer followed by surgical resection. J Surg Oncol. 2006;93:120–8.PubMedCrossRefGoogle Scholar
  33. 33.
    Earashi M, Noguchi M, Motoyoshi A, Fujii H. Radiofrequency ablation therapy for small breast cancer followed by immediate surgical resection or delayed mammotome excision. Breast Cancer. 2007;14:39–47.PubMedCrossRefGoogle Scholar
  34. 34.
    Manenti G, Bolacchi F, Perretta T, el. Small breast cancers: in vivo percutaneous US-guided radiofrequency ablation with dedicated cool-tip radiofrequency system. Radiology. 2009;251:339–46.Google Scholar
  35. 35.
    Wiksell H, Löfgren L, Schässburger KU, et al. Feasibility study on the treatment of small breast carcinoma using percutaneous US-guided preferential radiofrequency ablation (PRFA). Breast. 2010;19:219–25.PubMedCrossRefGoogle Scholar
  36. 36.
    Oura S, Tamaki T, Hirai I, et al. Radiofrequency ablation therapy in patients with breast cancers two centimeters or less in size. Breast Cancer. 2007;14:48–54.PubMedCrossRefGoogle Scholar
  37. 37.
    Brkljacic B, Cikara I, Ivanac G, et al. Ultrasound-guided bipolar radiofrequency ablation of breast cancer in inoperable patients: a pilot study. Ultraschall Med. 2010;31:156–62.PubMedCrossRefGoogle Scholar
  38. 38.
    Susini T, Nori J, Olivieri S, et al. Radiofrequency ablation for minimally invasive treatment of breast carcinoma. A pilot study in elderly inoperable patients. Gynecol Oncol. 2007;104:304–10.Google Scholar
  39. 39.
    Marcy PY, Magné N, Castadot P, Bailet C, Namer M. Ultrasound-guided percutaneous radiofrequency ablation in elderly breast cancer patients: preliminary institutional experience. Br J Radiol. 2007;80:267–73.PubMedCrossRefGoogle Scholar
  40. 40.
    Yamamoto N, Fujimoto H, Nakamura R, et al. Pilot study of radiofrequency ablation therapy without surgical excision for T1 breast cancer: evaluation with MRI and vacuum-assisted core needle biopsy and safety management. Breast Cancer. 2011;18:3–9.PubMedCrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2011

Authors and Affiliations

  • V. Suzanne Klimberg
    • 1
    • 2
  • Cristiano Boneti
    • 1
  • Laura L. Adkins
    • 1
  • Maureen Smith
    • 1
  • Eric Siegel
    • 3
  • Vladimir Zharov
    • 4
  • Scott Ferguson
    • 4
  • Ronda Henry-Tillman
    • 1
  • Brian Badgwell
    • 5
  • Soheila Korourian
    • 2
  1. 1.Division of Breast Surgical Oncology, Department of SurgeryUniversity of Arkansas for Medical Sciences, Winthrop P. Rockefeller Cancer InstituteLittle RockUSA
  2. 2.Department of PathologyUniversity of Arkansas for Medical SciencesLittle RockUSA
  3. 3.Department of Biostatics, College of Public HealthUniversity of Arkansas for Medical Sciences, Winthrop P. Rockefeller Cancer InstituteLittle RockUSA
  4. 4.Phillips Classic Laser and Nanomedicine LaboratoriesUniversity of Arkansas for Medical Sciences, Winthrop P. Rockefeller Cancer InstituteLittle RockUSA
  5. 5.Department of SurgeryUniversity of Arkansas for Medical Sciences, Winthrop P. Rockefeller Cancer InstituteLittle RockUSA

Personalised recommendations